ChemoMouthpiece has filed a notice of an exempt offering of securities to raise $34,069,098.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ChemoMouthpiece is raising up to $34,069,098.00 in new funding. Sources indicate that as part of senior management President, David Yoskowitz played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About ChemoMouthpiece
Chemo Mouthpiece, LLC is an oncology supportive care company. The Chemo Mouthpiece device is an intraoral ice pack that delivers cryotherapy to the oral cavity of a patient receiving chemotherapy. It proactively manages and treats oral mucositis, a common and painful side effect of chemotherapy. The product was recently granted Breakthrough Device Designation by the FDA for the reduction in incidence and severity of oral mucositis caused by chemotherapy and allows patients to continue their treatment with less discomfort and disruption in their daily lives. The Chemo Mouthpiece device was developed based on the personal experience of inventor, founder and CEO David Yoskowitz, who when diagnosed with Hodgkins Lymphoma experienced oral mucositis firsthand. His treatment options included ice chips to mitigate and minimize the pain. Yet this caused nausea, was difficult to maintain in his mouth, and did not effectively cool the entire oral cavity which led him to search for a better option. An engineer by trade, he made it his mission to find a better way for cancer patients to cope with oral mucositis during treatment. He created a simple, effective, easy-to-use device to be used during chemotherapy treatments at home or in a hospital. The Chemo Mouthpiece efficiently cools the entire oral cavity. Patients can freeze the device at home and take it with them to be used during treatment, creating a simple solution for an unmet patient need.
To learn more about ChemoMouthpiece, visit http://chemomouthpiece.com/
Contact:
David Yoskowitz, President
866-461-7518
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.